ADMA Biologics Inc (ADMA)
18.29
-0.84
(-4.39%)
USD |
NASDAQ |
Jan 07, 16:00
18.29
0.00 (0.00%)
After-Hours: 16:23
ADMA Biologics Research and Development Expense (Annual): 3.30M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Corcept Therapeutics Inc | 184.35M |
| Catalyst Pharmaceuticals Inc | 93.15M |
| Alnylam Pharmaceuticals Inc | 1.004B |
| Sarepta Therapeutics Inc | 877.39M |
| Stoke Therapeutics Inc | 82.23M |